Latest Headlines
CATEGORY
-
2021-10-21Singapore-based Biosyngen receives 500 million yuan in investmentThe investment will allow the biotech form to shorten the time to mass production for their tumor cell therapy pipelines and to speed up clinical research on cutting-edge therapies against solid tumorsREAD MORE -
2021-10-20S’pore-based firm Biosyngen working on harnessing theSINGAPORE - Scientists are increasingly looking at a new type of treatment - which involves harnessing a patient's own immune cells and improving them, so that they are better able to fight cancer.READ MORE
